Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment

International Journal of Antimicrobial Agents

Volumn 47, Issue 2, 2016, Pages 163-167

  Kolpen, Mette ^a,b   Mousavi, Nabi ^a   Sams, Thomas ^c   Bjarnsholt, Thomas ^a,b   Ciofu, Oana ^b   Moser, Claus ^a   Kühl, Michael ^d,e   Høiby, Niels ^a,b   Jensen, Peter ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Biofilm; Ciprofloxacin; Cystic fibrosis; Hyperbaric oxygen treatment; Pseudomonas aeruginosa

Indexed keywords

CIPROFLOXACIN; OXYGEN; ANTIINFECTIVE AGENT;

AEROBIC METABOLISM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIZATION; HYPERBARIC OXYGEN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REOXYGENATION; DRUG EFFECTS; HYDROSTATIC PRESSURE; MICROBIAL VIABILITY; PHYSIOLOGY;

AEROBIOSIS; ANTI-BACTERIAL AGENTS; BIOFILMS; CIPROFLOXACIN; HYDROSTATIC PRESSURE; MICROBIAL VIABILITY; OXYGEN; PSEUDOMONAS AERUGINOSA;

EID: 84956843243     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.12.005     Document Type: Article

References (20)

1. N. Hoiby, O. Ciofu, and T. Bjarnsholt Pseudomonas aeruginosa biofilms in cystic fibrosis Future Microbiol 5 2010 1663 1674
2. D. Worlitzsch, R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K.C. Meyer, and et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients J Clin Invest 109 2002 317 325
3. M. Kolpen, M. Kühl, T. Bjarnsholt, C. Moser, C.R. Hansen, L. Liengaard, and et al. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection PLOS ONE 9 2014 e84353
4. E.S. Cowley, S.H. Kopf, A. LaRiviere, W. Ziebis, and D.K. Newman Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation mBio 6 2015 e00767
5. M. Kolpen, C.R. Hansen, T. Bjarnsholt, C. Moser, L.D. Christensen, M. van Gennip, and et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis Thorax 65 2010 57 62
6. M. Kolpen, T. Bjarnsholt, C. Moser, C.R. Hansen, L.F. Rickelt, M. Kühl, and et al. Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen Clin Exp Immunol 177 2014 310 319
7. K.N. Kragh, M. Alhede, P.∅. Jensen, C. Moser, T. Scheike, C.S. Jacobsen, and et al. Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients Infect Immun 82 2014 4477 4486
8. C. Alvarez-Ortega, and C.S. Harwood Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration Mol Microbiol 65 2007 153 165
9. M. Eschbach, K. Schreiber, K. Trunk, J. Buer, D. Jahn, M. Schobert, and et al. Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation J Bacteriol 186 2004 4596 4604
10. T. Bjarnsholt, O. Ciofu, S. Molin, M. Givskov, and N. Høiby Applying insights from biofilm biology to drug development - can a new approach be developed? Nat Rev Drug Discov 12 2013 791 808
11. M.C. Walters 3rd, F. Roe, A. Bugnicourt, M.J. Franklin, and P.S. Stewart Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin Antimicrob Agents Chemother 47 2003 317 323
12. R.P. Brochmann, A. Toft, O. Ciofu, A. Briales, M. Kolpen, C. Hempel, and et al. Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation Int J Antimicrob Agents 43 2014 140 147
13. D.J. Dwyer, P.A. Belenky, J.H. Yang, I.C. MacDonald, J.D. Martell, N. Takahashi, and et al. Antibiotics induce redox-related physiological alterations as part of their lethality Proc Natl Acad Sci U S A 111 2014 E2100 E2109
14. B. Peng, Y.B. Su, H. Li, Y. Han, C. Guo, Y.M. Tian, and et al. Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria Cell Metab 21 2015 249 261
15. L.M. Pakman Inhibition of Pseudomonas aeruginosa by hyperbaric oxygen. I. Sulfonamide activity enhancement and reversal Infect Immun 4 1971 479 487
16. F.L. Lima, P.P. Joazeiro, M. Lancellotti, L.M. de Hollanda, B. de Araújo Lima, E. Linares, and et al. Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages Future Microbiol 10 2015 179 189
17. M.A. Kohanski, D.J. Dwyer, B. Hayete, C.A. Lawrence, and J.J. Collins A common mechanism of cellular death induced by bactericidal antibiotics Cell 130 2007 797 810
18. P.∅. Jensen, A. Briales, R.P. Brochmann, H. Wang, K.N. Kragh, M. Kolpen, and et al. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms Pathog Dis 70 2014 440 443
19. D.J. Evans, D.G. Allison, M.R. Brown, and P. Gilbert Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate J Antimicrob Chemother 27 1991 177 184
20. M. Cimsit, G. Uzun, and S. Yildiz Hyperbaric oxygen therapy as an anti-infective agent Expert Rev Anti Infect Ther 7 2009 1015 1026